Related Experiment Video
Updated: May 23, 2026
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
A network analysis of symptom clusters and core symptoms in colorectal cancer patients undergoing postoperative
Bingbing Xiao1,2,3, Wendan Jing1,2, Jiayi Wang1,2,3
1Sichuan Branch of National Clinical Research Center for Digestive Diseases, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Objective:
To identify symptom clusters in patients after colorectal cancer surgery upon completion of six cycles of chemotherapy and to determine core symptoms using network analysis, thereby providing evidence for developing precise symptom management strategies.
Methods:
A cross-sectional study was conducted. A convenience sample of 211 patients who had completed six cycles of chemotherapy after colorectal cancer surgery was recruited from two tertiary hospitals between February and October 2025. Participants were assessed using the MD Anderson Symptom Inventory for Gastrointestinal Cancer (MDASI-GI). Symptom clusters were extracted via exploratory factor analysis, and a symptom network was constructed using R software to identify core symptoms.
Results:
Three symptom clusters were identified: gastrointestinal-psychological, neurotoxicity, and CRC-specific. Network analysis revealed that "Poor appetite" had the highest node strength (r s=1.362) and expected influence (r e=1.362), while "Nausea" had the highest closeness centrality (r c=0.007) and betweenness centrality (r b=48). Fatigue had the highest incidence rate (89.6%).
Conclusion:
Poor appetite and nausea are key symptoms in the symptom network of colorectal cancer patients after surgery and chemotherapy. In clinical practice, giving priority to managing these two core symptoms, while routinely addressing fatigue as a high-frequency concern, may improve patients' overall symptom experience more effectively and enable more focused care.
Related Concept Videos
01:21Cancer Survival Analysis
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers